Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFIS in Mechanically Ventilated Patients
NCT02218359Phase 2Withdrawn
- Sponsor
- Cardeas Pharma Corp.
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of amikacin liposome inhalation suspension, fosfomycin in bacterial colonization, sponsored by Cardeas Pharma Corp.. Planned start Oct 2014; status: withdrawn.
02
Drugs
amikacin liposome inhalation suspensionfosfomycin
03
Conditions
bacterial colonization
Beyond the preview
Go deeper on NCT02218359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218359.